Live attenuated vaccines
|
/strong>
-
The virulence of the pathogen is reduced and immunogenicity is maintained by adapting the pathogen in an unfavourable condition and the organism still replicates.
-
Attenuation is achieved by growing the pathogens in an unnatural host, by passaging in non homologous host (host/cell culture) for repeated period of time (i.e. 70-80 times) or in different physiological conditions or in different environment.
-
Attenuation may also be done by adapting the virus to grow in a temperature lower than the normal called cold adapted virus and the process is called cold adaption.
-
Thermo stable vaccine strain grows at elevated temperature.
-
Temperature sensitive mutants cannot grow at slightly elevated temperature.
-
The process of reducing the virulence and retaining the immunogenicity is called as attenuation so that the pathogen changes its habit of growing.
-
Advantages
-
Replication provides large quantities of immunogen
-
There is no need for adjuvant
-
Single dose often produce long lasting immunity
-
Whole organism has both T and B epitopes
-
The vaccine is cost effective and often does not require booster vaccination
-
Can be effective against intracellular pathogens
-
Disadvantages
-
Chance of reversion to virulence
-
There may be shedding of virus
-
Can induce transient immunosupression
-
Cold chain required for transport
-
Possible contamination with other animal viruses
-
There may be side effects due to unwanted parts of the vaccines.
|
Last modified: Thursday, 26 August 2010, 10:22 AM